Abstract
Autoimmune thyroid disease (AITD) is caused by an immune response to self-thyroid antigen. The cytotoxic T-lymphocyte antigen-4 (CTLA4) gene, encoding a negative regulator of the T-lymphocyte immune response, had been reported to be associated and/or linked to AITD. Recently, AITD susceptibility in the Caucasians was mapped to the 6.1-kb 3′UTR of the CTLA4 gene, in which the three single-nucleotide polymorphisms (SNPs) CT60, JO31, and JO30 were strongly associated with AITD. In order to determine the association of the CTLA4 gene with AITD in the Japanese, case-control association analysis for the four SNPs of the CTLA4 gene using 380 AITD patients and 266 healthy controls was done. Among the SNPs examined, the SNP JO31 was most significantly associated with AITD in the Japanese, whereas the association of the JO30 with AITD was not observed. The frequency of the disease-susceptible G allele of the JO31 of the Japanese control was higher than that of the Caucasians (67.1% vs 50.2%); however, the G allele of the JO31 was associated with Graves’ disease (GD) (67.1% vs 76.3%, P=0.0013) and AITD in the Japanese (67.1% vs 74.2%, P=0.0055). Furthermore, the G allele of the JO31 was associated with the increased risk for GD [P=0.0051, odds ratio (OR)=1.7] and AITD (P=0.016, OR=1.5) in a dominant model. These results suggested that the CTLA4 gene is involved in the susceptibility for GD and AITD in the Japanese.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Dong RP, Kimura A, Okubo R, Shinagawa H, Tamai H, Nishimura Y, Sasazuki T (1992) HLA-A and DPB1 loci confer susceptibility to Graves’ disease. Hum Immunol 35:165–172
Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K (1997) CTLA4 Alanine-17 confers genetic susceptibility to Graves’ disease and to type I diabetes mellitus. J Clin Endocrinol Metab 82:143–146
Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K, Carr-Smith J, Daykin J, Daly A, Sheppard MC, Holder RL, Barnett AH, Franklyn JA, Gough SC (1999) The development of Graves’ disease and the CTLA4 gene on chromosome 2q33. J Clin Endocrinol Metab 84:2398–2401
Kotsa K, Watson PF, Weetman AP (1997) A CTLA4 gene polymorphism is associated with both Graves’ disease and autoimmune hypothyroidism. Clin Endocrinol 46:551–554
Risch N (1990) Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46:229–241
Risch N, Merikangas K (1996) The future of genetic studies of complex human disease. Science 273:1516–1517
Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T (2001) Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto’s thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 13:1379–1386
Stassi G, De Maria R (2002) Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2:195–204
Ueda H, Howson JMM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KMD, Smith AN, Genova GD, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RCJ, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithlyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Renningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SCL (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506–511
Uno H, Sasazuki T, Tamai H, Matsumoto H (1981) Two major genes, linked to HLA and Gm, control susceptibility to Graves’ disease. Nature 292:768–770
Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy MI, Kendall-Taylor P, Pearce SHS (1999a) Cytotoxic T lymphocyte antigen-4 (CTLA4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet 354:743–744
Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, McCarthy MI, Kendall-Taylor P, Peatce SHS (1999b) The cytotoxic T lymphocyte antigen-4 is a major Graves’ disease locus. Hum Mol Genet 8:1195–1199
Wan XL, Kimura A, Dong RP, Honda K, Tamai H, Sasazuki T (1995) HLA-A and -DRB4 genes in controlling the susceptibility to Hashimoto’s thyroiditis. Hum Immunol 42:131–136
Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ (1995) CTLA4 gene polymorphism associated with Graves’ disease in a Caucasian population. J Clin Endocrinol Metab 80:41–45
Acknowledgements
We thank all patients for participating in this study and S. Ohkubo for preparation of the manuscript. This work was supported by a grant-in-aid for scientific research on priority areas “Medical Genome Science” from the Ministry of Education, Science, Technology, Sports and Culture, Japan, and a grant-in-aid for scientific research (A) from the Japan Society for the Promotion of the Science.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Furugaki, K., Shirasawa, S., Ishikawa, N. et al. Association of the T-cell regulatory gene CTLA4 with Graves’ disease and autoimmune thyroid disease in the Japanese. J Hum Genet 49, 166–168 (2004). https://doi.org/10.1007/s10038-003-0120-5
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s10038-003-0120-5
Keywords
This article is cited by
-
Pooled genome wide association detects association upstream of FCRL3 with Graves’ disease
BMC Genomics (2016)
-
GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis
Nature Reviews Endocrinology (2013)
-
Genetics of autoimmune thyroid disease in the Lebanese population
Journal of Community Genetics (2012)
-
Identification of independent risk loci for Graves’ disease within the MHC in the Japanese population
Journal of Human Genetics (2011)
-
Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial
Journal of Translational Medicine (2010)
